271 related articles for article (PubMed ID: 21968011)
1. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
[TBL] [Abstract][Full Text] [Related]
2. Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Am J Kidney Dis; 2009 Oct; 54(4):711-20. PubMed ID: 19619922
[TBL] [Abstract][Full Text] [Related]
3. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
[TBL] [Abstract][Full Text] [Related]
4. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
5. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
[TBL] [Abstract][Full Text] [Related]
6. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
[TBL] [Abstract][Full Text] [Related]
7. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
8. Icodextrin reduces mortality and the drop-out rate in Japanese peritoneal dialysis patients.
Kuriyama R; Tranaeus A; Ikegami T
Adv Perit Dial; 2006; 22():108-10. PubMed ID: 16983951
[TBL] [Abstract][Full Text] [Related]
9. Practical considerations when prescribing icodextrin: a narrative review.
Silver SA; Harel Z; Perl J
Am J Nephrol; 2014; 39(6):515-27. PubMed ID: 24925229
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
[TBL] [Abstract][Full Text] [Related]
11. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.
Yang X; Fang W; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):82-92. PubMed ID: 18178952
[TBL] [Abstract][Full Text] [Related]
12. Risk of and Fatality from Acute Pancreatitis in Long-Term Hemodialysis and Peritoneal Dialysis Patients.
Wang IK; Lai SW; Lai HC; Lin CL; Yen TH; Chou CY; Chang CT; Huang CC; Sung FC
Perit Dial Int; 2018; 38(1):30-36. PubMed ID: 29097488
[TBL] [Abstract][Full Text] [Related]
13. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
14. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
15. How to improve survival in geriatric peritoneal dialysis patients.
Hiramatsu M;
Perit Dial Int; 2007 Jun; 27 Suppl 2():S185-9. PubMed ID: 17556302
[TBL] [Abstract][Full Text] [Related]
16. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
[TBL] [Abstract][Full Text] [Related]
18. An update on peritoneal dialysis solutions.
García-López E; Lindholm B; Davies S
Nat Rev Nephrol; 2012 Feb; 8(4):224-33. PubMed ID: 22349485
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the use of icodextrin in peritoneal dialysis patients.
Johnson DW; Agar J; Collins J; Disney A; Harris DC; Ibels L; Irish A; Saltissi D; Suranyi M
Nephrology (Carlton); 2003 Feb; 8(1):1-7. PubMed ID: 15012742
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
